Debezium vs Managed CDC: How to Actually Decide Between Build and Buy

#dataengineering #database #cdc

Most "Debezium vs managed tool" articles get the question wrong. They frame it as a product bake-off, feature grid included, and declare a winner. But if you've actually run change data capture in production, you know the real decision isn't which tool captures a transaction log better. They mostly read the same logs the same way. The real decision is who operates everything that sits around the capture, and whether that work is a good use of your team's time.

That's a build-vs-buy question, not a product question. This post is a framework for answering it for your own situation.

First, let's kill an outdated assumption

A lot of Debezium criticism floating around is two or three years stale, and if you repeat it in 2026 you'll get corrected fast. So let's set the record straight before we compare anything.

Debezium is no longer just “the thing you run with Kafka Connect.” In recent Debezium 3.x releases, the project has become much more flexible than the old tutorials suggest. Today, you have several deployment options:

Kafka Connect, the classic setup, which gives you the Kafka ecosystem, distributed fault tolerance, durable schema history, and access to Kafka Connect sink connectors.
Debezium Server, a standalone application that streams changes to systems like Amazon Kinesis, Google Cloud Pub/Sub, Apache Pulsar, Redis Streams, or NATS JetStream without requiring Kafka.
Debezium Management Platform, which builds on Debezium Server and the Debezium Operator to provide a higher-level way to configure and manage CDC pipelines in Kubernetes-style environments.
Embedded usage, where you run Debezium Engine inside your own application. Recent Debezium releases also added framework support such as the Quarkus extension.

A few more things are worth knowing so the comparison is fair:

Kafka 4.x runs in KRaft mode, and ZooKeeper mode has been removed. “You need to babysit ZooKeeper” is no longer true for a modern Kafka deployment.
Debezium's default remains at-least-once delivery, so duplicates are possible on failures and restarts. Since Debezium 3.3, exactly-once support is available for core connectors when running through Kafka Connect with transactional support enabled. Outside that boundary, you still need idempotent consumers or downstream deduplication.

None of this makes Debezium the wrong choice. It makes it a more capable and more flexible choice than the old tutorials suggest. Keep that in mind, because a fair comparison is the only kind worth reading.

What you are actually comparing

Here's the mental model I'd start from. A CDC pipeline has two parts:

The capture engine. It reads the database transaction log (the Postgres WAL, the MySQL binlog, the SQL Server change tables) and emits row-level change events. This is the part Debezium does extremely well, and it's genuinely the easy part.
Everything around the capture. Backfilling historical data and reconciling it with the live stream. Handling schema changes so a new column doesn't break a downstream job. Delivering to your actual destinations. Monitoring lag, retries, and dead letters. Scaling, upgrades, and the 2 a.m. page when a replication slot fills up and your source database's disk starts climbing.

Whichever path you pick, part one is close to solved. The entire build-vs-buy decision lives in part two.

When you "build," you take Debezium (or another open-source engine) and you own part two. When you "buy," you pay a vendor to own most of part two for you. That's the whole trade, stated plainly.

The real cost of building

Debezium itself is free and Apache-licensed. That number is real, and it's zero. The cost shows up everywhere else, so budget for these honestly:

Engineering time to design and stand up the pipeline. Not just the connector config, but the surrounding services: sinks, schema handling, and whatever glue your destinations need.
Backfill and snapshot coordination. Loading history and then switching to the live stream without gaps or duplicates is finicky. Debezium's incremental snapshots help a lot here, but you still own the behavior.
Schema evolution. Debezium can emit schema-change information for supported connectors, but turning that into safe downstream schema evolution is still something you own. This is one of the most common sources of production breakage in home-grown pipelines.
Destination management. Debezium is a capture tool by design. Getting data into Snowflake, BigQuery, or an operational store means Kafka Connect sink connectors or your own consumers, each with their own limits.
Delivery guarantees. If you need exactly-once, you're running on Kafka Connect with EOS configured, or you're building idempotent consumers. That's real design work, not a checkbox.
Monitoring, on-call, and upgrades. Lag dashboards, alerting, dead-letter handling, and version upgrades across connectors. This never fully ends; it's a standing operational commitment.

The honest version of the build case: if you have the engineering depth, want full control, need to avoid vendor lock-in, and CDC is close enough to your core competency that owning it makes sense, building is a completely reasonable choice. Plenty of strong data teams run Debezium in production and are happy. The newer deployment modes (Server and the Management Platform) meaningfully reduce the operational surface compared to the full Kafka setup, so the "build" side is lighter than it used to be.

Where building goes wrong is when a team picks it to save money, undercounts part two, and discovers six months later that a senior engineer is effectively a part-time CDC platform operator.

The real cost of buying

Managed CDC platforms take part two off your plate. You connect a source, pick a destination, and the vendor handles snapshots, schema handling, delivery, scaling, and recovery. The catalog here includes Estuary, Fivetran, Airbyte Cloud, Confluent Cloud, and the cloud-native services like AWS DMS and Google Datastream. They differ in meaningful ways:

Fivetran is the managed ELT leader with the largest connector catalog. CDC is part of a broader platform, latency is typically schedule-based and often measured in minutes depending on connector and plan, and pricing is based on monthly active rows, which can surprise fast-growing teams.
Airbyte is open-core with 600+ connectors. For selected database CDC sources, it uses Debezium-based log capture under the hood. Self-host for control, or use the cloud tier for convenience.
Confluent Cloud is the natural fit if you want managed Kafka plus Debezium connectors with deep Kafka integration.
Cloud-native services like AWS DMS, Google Datastream, and Azure Data Factory can be convenient inside their own cloud, but cross-cloud use, egress, connector behavior, and feature support all need careful review.
Estuary is streaming-first, built on its own Gazette-based runtime rather than Kafka, with sub-second data movement for many use cases and exactly-once semantics where the destination supports transactional commits. It captures once and lets you reuse that stream across many destinations, and it exposes a Kafka-compatible interface, Dekaf, so consumers can read Estuary collections as if they were Kafka topics. It offers public SaaS, private, and BYOC deployments.

Note: I work at Estuary, one of the managed CDC platforms mentioned here. This post is meant as a practical build-vs-buy framework, not a product ranking.

Buying isn't free of tradeoffs, and pretending otherwise is how you lose a technical audience. Be clear-eyed about the buy side:

Recurring cost that scales with your data. At high volume, a managed bill can exceed the cost of running Debezium yourself. Model this at your real and projected volumes, not today's.
Less low-level control. You get the vendor's abstractions. If you need to fork the capture logic or do something exotic, a managed platform may not let you.
Lock-in and pricing-model risk. Different vendors bill on rows, connectors, or compute. A model that's cheap now can get expensive as you grow, and migrating off later is real work.
Security and data-residency review. Routing production data through a third party means a procurement and compliance conversation. BYOC and private deployments exist partly to answer this.

The decision framework

Here's how I'd actually decide. Score your situation against these, and let the weight fall where it falls.

Lean toward building (Debezium) if:

You have engineers who know, or want to own, streaming infrastructure.
Avoiding vendor lock-in is a hard requirement.
You need deep customization of the capture or event-processing logic.
CDC is central enough to your product that operating it is a reasonable investment.
You're comfortable owning backfills, schema propagation, and on-call.

Lean toward buying if:

Your team's time is better spent on product than on pipeline plumbing.
You need data in warehouses or apps quickly, without a multi-week build.
You want backfills, schema handling, and delivery guarantees handled for you.
You'd rather scale a bill than a Kafka Connect cluster.
Reliability and low-latency delivery matter more than low-level control.

A useful gut check: if the pipeline going down at 2 a.m. is your problem to fix, you're building. If it's a support ticket, you're buying. Decide which of those you want to sign up for.

A quick way to compare true cost

Don't compare a license fee to a subscription. Compare total cost of ownership over, say, two years. A rough model:

Build (Debezium) TCO = infrastructure (Kafka or the runtime you choose, plus storage and egress) + fully loaded engineering time to build it + ongoing operational time (monitoring, on-call, upgrades, incident response) + the cost of the occasional data incident.

Buy (managed) TCO = the subscription at your real volume + integration time + the internal cost of vendor and security review + any egress the platform passes through.

The line that catches teams off guard is "ongoing operational time." A conservative half-day a week of senior engineer time on pipeline maintenance is roughly 20-plus days a year. Price that against a subscription before you conclude that build is cheaper. Sometimes it genuinely is, especially at very high volume. Often it isn't once you count honestly.

When each choice tends to win

A couple of concrete patterns, since frameworks are easier to use with examples:

A five-person startup needs Postgres data in Snowflake for analytics next sprint. Buy. There's no world where hand-rolling a Kafka Connect pipeline is the right use of that team's month.
A large engineering org is already deep in Kafka, has an SRE function, and wants event streams feeding dozens of microservices with custom processing. Build. Debezium on Kafka Connect fits the existing competency, and the control is worth the operational cost.
A mid-size team needs the same change stream in a warehouse, an operational store, and a search index, and wants it reliable without becoming Kafka operators. This is where managed streaming platforms can make sense. Capture once, fan out, and don't run the brokers yourself.

Most teams aren't at the extremes. The framework is there to tell you which way you actually lean once you weigh the factors that matter to you.

Bottom line

Debezium and managed CDC platforms are not really competing on capture quality. They're offering you two different deals on the work that surrounds the capture. Building means you own that work in exchange for control and a lower license cost. Buying means you rent someone else's operations in exchange for speed and a predictable bill.

Neither is the smart choice in the abstract. The smart choice is the one that matches your team's skills, your data volume, and how much of your engineering attention you want CDC to consume. Run the framework, price the real total cost, and pick with your eyes open.

If you're on the build side, the Debezium docs are excellent and the community is genuinely helpful. If you're leaning toward buy, evaluate a few platforms against your actual sources and destinations before committing, because the right fit depends on your stack, not on anyone's feature grid.

If you're evaluating the managed side of this decision, Estuary is one option worth testing, especially if you need low-latency CDC, exactly-once semantics where supported, and the ability to reuse the same change stream across multiple destinations. The best way to evaluate it is the same way you should evaluate any managed CDC platform: try it against your real source, destination, schema changes, and expected data volume.

What did I miss? If you've run Debezium at scale or moved between build and buy, I'd like to hear how the tradeoffs actually played out for you.